| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $48.09 | $192,360.00 | -14.4% | |
| Apr 8, 2019 | Schoeneck James A47 | Director | Sale+OE | 2,000 | $52.90 | $105,800.00 | -6.7% | |
| Apr 8, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $53.03 | $212,120.88 | -7.7% | |
| Apr 4, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $54.07 | $2,143,194.96 | -0.3% | |
| Mar 21, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $55.52 | $2,200,618.54 | -0.4% | |
| Mar 19, 2019 | Cotroneo Pat | SVP, Finance And CFO | Sell | 7,665 | $55.41 | $424,717.65 | -3.1% | |
| Mar 14, 2019 | Yu K Peony | Chief Medical Officer | Sell | 9,145 | $56.30 | $514,863.50 | -4.8% | |
| Mar 7, 2019 | Schoeneck James A47 | Director | Sale+OE | 2,000 | $54.74 | $109,471.80 | -3.5% | |
| Mar 7, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $55.65 | $2,205,818.60 | -0.3% | |
| Feb 28, 2019 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 14,787 | $60.08 | $888,391.13 | -5.5% |